Expressions of glia maturation factor-β by tumor cells and endothelia correlate with neovascularization and poor prognosis in human glioma

Xiao‐Yan Kuang, Xuefeng Jiang, Cong Chen, Xiaorui Su, Yu Shi, Jinrong Wu, Peng Zhang, Xinli Zhang, You‐Hong Cui, Yi‐Fang Ping,

Oncotarget · 2015 · 12 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

// Xiao-yan Kuang 1, 2, * , Xue-feng Jiang 1, 2, * , Cong Chen 1, 2 , Xiao-rui Su 1, 2 , Yu Shi 1, 2 , Jin-rong Wu 1, 2 , Peng Zhang 1, 2 , Xin-li Zhang 1, 2, 3 , You-hong Cui 1, 2 , Yi-fang Ping 1, 2 , Xiu-wu Bian 1, 2, 4 1 Institute of Pathology and Southwest Cancer Center, Southwest Hospital, Third Military Medical University, Chongqing, China 2 Key Laboratory of Tumor Immunology and Pathology of Ministry of Education, Southwest Hospital, Third Military Medical University, Chongqing, China 3 Division of Growth and Development and Section of Orthodontics, School of Dentistry, University of California, Los Angeles, CA, USA 4 Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University, Guangzhou, China * These authors have contributed equally to the study Correspondence to: Xiu-wu Bian, email: bianxiuwu@263.net Yi-fang Ping, email: pingyifang@126.com Keywords: glia maturation factor-β, glioma, neovascularization, prognosis Received: March 17, 2015      Accepted: October 13, 2015      Published: October 26, 2015 ABSTRACT Glia maturation factor-β (GMF-β) has been reported to promote glial differentiation, and act as a negative prognostic indicator in certain cancers. However, its roles in glioma progression remain unclear. Since neurogenesis and vasculogenesis were proved to share some common regulators during gliomagenesis, we aim to explore the potential impact of GMF-β on tumor neovascularization and patient survival in glioma. In this study, we first detected GMF-β expression not only in tumor cells but also in microvascular endothelia by double immunohistochemical staining. Both tumoral and endothelial GMF-β expression levels were positively correlated with tumor grade and microvessel density (MVD), while negatively associated with poor prognoses of the patients. Interestingly, multivariate analysis demonstrated that endothelial GMF-β expression level was the only independent predictor of progression-free and overall survival of glioma patients. The results of in vitro angiogenesis assay showed that GMF-β knockdown significantly inhibited tubulogenesis of human U87 glioblastoma cells. Furthermore, GMF-β knockdown suppressed tumor growth and the formation of human-CD31 positive (glioma cell-derived) microvessels in a mouse orthotopic U87 glioma model. Our results demonstrated that GMF-β is an important player in glioma progression via promoting neovascularization. GMF-β may therefore be a novel prognostic marker as well as a potential therapeutic target for glioma.

References

21